Browsing Tag
Oxford BioDynamics
3 posts
Why Oxford BioDynamics (AIM: OBD) needs cash by August despite good news
Oxford BioDynamics just posted its best test order growth yet, hired a top genomics CEO, and still needs cash by August. The gap says everything.
Oxford BioDynamics collaborates with National Cancer Institute in prostate cancer clinical trial
Oxford BioDynamics Plc (AIM: OBD), a pioneering biotechnology company, has announced its participation in a significant clinical trial…
Oxford BioDynamics partners with Goodbody Clinic to enhance prostate cancer screening across UK
Oxford BioDynamics Plc, a leader in developing precision medicine tests, has partnered with Goodbody Clinic, a major provider…